Skip to content
Study details
Enrolling now

Effects of Cannabidiol on Stress and Nicotine Withdrawal

Johns Hopkins University
NCT IDNCT07001930ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

90

Study length

about 4 years

Ages

21–70

Locations

1 site in MD

What this study is about

This trial is testing if cannabidiol (CBD) can help with stress and nicotine withdrawal in people who use nicotine. Researchers will give CBD to participants experiencing stress and nicotine withdrawal, collecting data through biological measures and participant reports.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Epidiolex

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Diastolic Blood Pressure (mmHg), Heart Rate (beats per minutes), Systolic Blood Pressure (mmHg)

Secondary: Subjective Pain as assessed by the McGill Pain Questionnaire short form (MPQ)